Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression (NCT07226232)
A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
Who can join: Review the eligibility criteria below.
Location: Birmingham VA Medical Center, Birmingham, AL — Birmingham, Alabama
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Birmingham VA Medical Center, Birmingham, AL — Birmingham, Alabama
- Tuscaloosa VA Medical Center, Tuscaloosa, AL — Tuscaloosa, Alabama
- VA Portland Health Care System, Portland, OR — Portland, Oregon
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA — Philadelphia, Pennsylvania
- VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (205) 554-3819
Email: lori.davis@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Major Depression
- Study of Psilocybin Under Anesthesia Controlled by EEG — Stanford, California
- Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder — Belmont, Massachusetts
- Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 — Belmont, Massachusetts
- Leucine in Midlife Depression — Atlanta, Georgia
- Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project — San Francisco, California
- Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression — Belmont, Massachusetts
Explore by condition: All Major Depression clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.